Hormonal contraceptives: pharmacology tailored to women's health

To pill or not to pill in GnRH antagonist cycles: that is the question!

(2015) Juan A. Garcia-Velasco et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review

(2013) J. M. Gierisch et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism

(2013) Vincenzo De Leo et al.   CONTRACEPTION

Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection

(2013) Asia Asiaf et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Pharmacokinetic evaluation of desogestrel as a female contraceptive

(2013) Giovanni Grandi et al.   Expert Opinion on Drug Metabolism & Toxicology

Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis

(2013) B. H. Stegeman et al.   BMJ-British Medical Journal

Epidemiology, diagnosis, and management of polycystic ovary syndrome

(2013) Susan Sirmans et al.   Clinical Epidemiology

Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5

(2012) C. Neill Epperson et al.   AMERICAN JOURNAL OF PSYCHIATRY

History of oral contraceptive drugs and their use worldwide

(2012) Sophie Christin-Maitre   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence

(2012) David Cibula et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Screening Women for Oral Contraception

(2012) David A. Grimes et al.   OBSTETRICS AND GYNECOLOGY

Committee Opinion No. 539

(2012)   OBSTETRICS AND GYNECOLOGY

Risk factors for venous thromboembolism in pre-and postmenopausal women

(2012) Annica Bergendal et al.   THROMBOSIS RESEARCH

Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study

(2011) N. Gronich et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?

(2011) Anne Guivarc’h-Levêque et al.   FERTILITY AND STERILITY

Combined oral contraceptives in women with menstrual migraine without aura

(2011) Vincenzo De Leo et al.   FERTILITY AND STERILITY

Hormonal Contraceptives and the Length of Their Use Are Not Independent Risk Factors for High-Risk HPV Infections or High-Grade CIN

(2011) Adhemar Longatto-Filho et al.   GYNECOLOGIC AND OBSTETRIC INVESTIGATION

The Epidemiology of Endometrial and Ovarian Cancer

(2011) Daniel W. Cramer   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

The FIGO Recommendations on Terminologies and Definitions for Normal and Abnormal Uterine Bleeding

(2011) Ian Fraser et al.   SEMINARS IN REPRODUCTIVE MEDICINE

Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome

(2010) Vincenzo De Leo et al.   CONTRACEPTION

Antiadipogenic Effects of the Mineralocorticoid Receptor Antagonist Drospirenone: Potential Implications for the Treatment of Metabolic Syndrome

(2010) Massimiliano Caprio et al.   ENDOCRINOLOGY

Low-dose Oral Contraceptives in Adolescents: How Low Can You Go?

(2010) H. Agostino et al.   Journal of Pediatric and Adolescent Gynecology

Recent Innovations in Oral Contraception

(2010) Miriam Cremer et al.   SEMINARS IN REPRODUCTIVE MEDICINE

Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study

(2010) Jürgen Dinger et al.   JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE

Spatiotemporal electromyography during human labor to monitor propagation of the uterine contraction wave and diagnose dystocia

(2009) Catalin S. Buhimschi   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Contraceptive considerations in obese women

(2009) Alison Edelman   CONTRACEPTION

Review of clinical experience with estradiol in combined oral contraceptives

(2009) Franca Fruzzetti et al.   CONTRACEPTION

Estradiol Valerate/Dienogest

(2009) Sheridan M. Hoy et al.   DRUGS

Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial

(2009) Santiago Palacios et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Contraceptive Hormone Use and Cardiovascular Disease

(2009) Chrisandra L. Shufelt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Early Weight Gain Predicting Later Weight Gain Among Depot Medroxyprogesterone Acetate Users

(2009) Yen-Chi L. Le et al.   OBSTETRICS AND GYNECOLOGY

Reproductive History, Oral Contraceptive Use, and the Risk of Ischemic and Hemorrhagic Stoke in a Cohort Study of Middle-Aged Swedish Women

(2009) Ling Yang et al.   STROKE

Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies

(2008) Jan Endrikat et al.   CONTRACEPTION

Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial

(2008) Angelo Cagnacci et al.   CONTRACEPTION

Oral Contraceptives in Polycystic Ovary Syndrome: Risk-Benefit Assessment

(2008) Bulent Yildiz   SEMINARS IN REPRODUCTIVE MEDICINE

Continuous oral contraception: changing times

(2007) Patricia J. Sulak   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis

(2007) George Griesinger et al.   FERTILITY AND STERILITY